The TNF recombinant monoclonal antibody, clone cA2 (Infliximab) from Abnova Corporation Monoclonal antibody to TNF, and Tumor necrosis factor. This antibody recognizes Homo Sapiens, and Human antigen. The TNF recombinant monoclonal antibody, clone cA2 (Infliximab) has been validated for the following applications: EIA, Immunoassay, ELISA, and Flow Cytometry.
Description
Recombinant rabbit monoclonal antibody raised against human TNF